Narendra Modi's Washington test

Narendra Modi's Washington test

If Modi gets the world’s biggest power right, his pursuit of larger global goals...
Small banks or banks for ‘small’ people?

Small banks or banks for ‘small’ people?

Unless appropriate sub-limits are imposed on loans, there is a serious...

Sun Pharma shares gain on US FDA approval of bone drug

Feb 19 2014, 13:00 IST
Comments 0
SummarySun Pharma has got US FDA approval to sell a drug to treat Osteoporosis in the US market.

Shares in Sun Pharmaceuticals Industries gain 1.5 per cent after the company got U.S. Food and Drug Administration approval to sell a drug to treat Osteoporosis, a bone-weakening disease.

Currently the drug, Ibandronate Sodium, is marketed by Roche under the brand name Bovina.

"Bovina generated an annual sales of $82 million in 2012. Currently, Sun Pharma is the only generic player to have final approval for this product," brokerage Sharekhan said in a note on Wednesday.

More players would be able to sell the drug after its patent expiry on Sept. 2, 2014, Sharekhan said.

Ads by Google

More from Markets

Reader´s Comments
| Post a Comment
Please Wait while comments are loading...